Biotech Research Trends

AlphaFold successors predicting not just structure but function and interaction — closing the loop from protein sequence to drug candidate.

Engineering entirely new biological systems — programmable cells, genetic circuits, and living factories producing materials, fuels, and medicines.

Programmable mRNA and viral vector platforms treating genetic disease, cancer, and infectious disease — the era of medicines that rewrite biology.

Large language and foundation models trained directly on DNA, RNA, and protein sequences — treating biology itself as a language to model and generate. Surfaced by the automated trend-discovery pass, not a hand-picked query.

Mapping every cell in the human body at spatial resolution — the biological foundation for precision medicine and an era of cellular-level diagnostics.

Base editors, prime editors, and in vivo delivery advancing CRISPR from a lab tool to clinical cures for genetic diseases affecting millions.

Senolytics, epigenetic reprogramming, and NAD+ metabolism research targeting the biology of aging itself — moving from lifespan extension to healthspan expansion.